Rota is a highly contagious virus that infects majority of children before their first birthday. It is the most common cause of severe diarrhea among children, leading to hospitalization and death.
Aiming to slash the prevalence of virus-borne diarrhea, the health ministry on Saturday, March 26, 2016, launched the Rota Virus vaccine, which will be available free of cost at public healthcare facilities, initially in four states.
'Made in India' Rotavirus Vaccine Claims to be Cheapest
India's first indigenously developed and manufactured rotavirus vaccine 'Rotavac' will be available for sale at the rate of around Rs 60 per dose from next week.
Advertisement
‘Aiming to slash the prevalence of diarrhea, the Indian health ministry launched the Rota Virus vaccine, initially in four states.’
Tweet it Now
Terming the occasion historic in the Indian health system, Health Minister J.P. Nadda said: "This is not a routine program. This Rota virus launch sets the goal in the field of Indian health system. By launching this, we aim to immunize 27 million children across the country to prevent diseases caused by Rota virus."
Nadda said that the government was aggressively working for the eradication of a slew of other diseases, including leprosy and TB. "It is our duty to see that every child born in the country is immunized against dreaded diseases," he said.
![Should Risk of Intussusception With Rotavirus Vaccine Deter the Use of the Vaccine?]( "Should Risk of Intussusception With Rotavirus Vaccine Deter the Use of the Vaccine?")
A Rotavirus vaccine was introduced in the past however it had to be withdrawn since 1 out of 10000 infants administered the vaccine suffered a serious complication called intussusception.
The National Technical Advisory Group on vaccines had recommended the phased introduction of Rota virus vaccine in the country's Universal Immunization Program.
In the first phase, Rota virus vaccine will be introduced in four States - Odisha, Himachal Pradesh, Haryana and Andhra Pradesh. It will be provided at government health facilities to children from six weeks of age. The vaccine was launched in Odisha as the state records high diarrhea cases among children and deaths due to improper treatment.
"We are making appropriate investment, and this has been possible because we have an effective healthcare system with more and more facilities capable of providing the vaccine to the needy children," said Health Ministry Additional Secretary C.K. Mishra.
Currently, 9.2% of Odisha's total disease burdens consists of diarrhea patients. The infant mortality rate in Odisha is 51 per 1,000 live births, while the mortality rate of children under five years is 68 per 1,000 births, both far higher than in the other states where the Rota virus vaccine was launched in the first phase on Saturday, March 26, 2016.
The diarrhea burden due to Rota virus in Andhra Pradesh stands at 8% while the figure in Haryana and Himachal Pradesh is 8.5% and 5.5% respectively.
Globally there are 453,000 child deaths due to Rota virus every year. In India, Rota Virus diarrhea causes about 78,000 deaths and about 8.7 lakh hospitalizations each year. Additionally, 32.7 lakh children under five years of age are treated as outpatients.
Source: IANS
Should Risk of Intussusception With Rotavirus Vaccine Deter the Use of the Vaccine?
A Rotavirus vaccine was introduced in the past however it had to be withdrawn since 1 out of 10000 infants administered the vaccine suffered a serious complication called intussusception.
Advertisement
The National Technical Advisory Group on vaccines had recommended the phased introduction of Rota virus vaccine in the country's Universal Immunization Program.
In the first phase, Rota virus vaccine will be introduced in four States - Odisha, Himachal Pradesh, Haryana and Andhra Pradesh. It will be provided at government health facilities to children from six weeks of age. The vaccine was launched in Odisha as the state records high diarrhea cases among children and deaths due to improper treatment.
"We are making appropriate investment, and this has been possible because we have an effective healthcare system with more and more facilities capable of providing the vaccine to the needy children," said Health Ministry Additional Secretary C.K. Mishra.
Currently, 9.2% of Odisha's total disease burdens consists of diarrhea patients. The infant mortality rate in Odisha is 51 per 1,000 live births, while the mortality rate of children under five years is 68 per 1,000 births, both far higher than in the other states where the Rota virus vaccine was launched in the first phase on Saturday, March 26, 2016.
The diarrhea burden due to Rota virus in Andhra Pradesh stands at 8% while the figure in Haryana and Himachal Pradesh is 8.5% and 5.5% respectively.
Globally there are 453,000 child deaths due to Rota virus every year. In India, Rota Virus diarrhea causes about 78,000 deaths and about 8.7 lakh hospitalizations each year. Additionally, 32.7 lakh children under five years of age are treated as outpatients.
Source: IANS
Delhi High Court Dismisses PIL On Clinical Trials Of Rotavirus Vaccine
The PIL was filed by a member of NTAGI seeking to restrain the government from moving on to phase IV trials in which over one lakh children would be administered the vaccine.
Advertisement
 Keeping Rotavirus at BayVirus such as influenza via specific characteristics of viral ribonucleic acid can be detected by our immunosensory system. | Advertisement
|
Advertisement
Recommended Reading
Latest Indian Health News
H3N2 Outbreak in India: Influenza and respiratory illnesses are spreading faster than ever before in India. Finding ways for better lung health can save lives from deadly viruses.
Is stroke common in India? Yes, a stroke kills one Indian every 4 minutes. Therefore, telemedicine in stroke treatment could save lives.
Across Karnataka, more than 50 cases of H3N2 have been reported. Karnataka government released detailed guidelines in this regard.
Silver Storm Water Theme Park in Athirappilly (Kerala) is temporarily closed as many students who bathed were affected with symptoms of the Zoonotic disease leptospirosis.
In Delhi in the last three months, a new sub-type of the influenza virus H3N2 has been in wide circulation. Experts warn against the use of antibiotics.